- Entry
- $7.28
- Final
- $6.26 -14.0%
- Target
- $28.00
- Score
- -0.05
**$WVE:** Wave Life Sciences *This is a clinical stage biotech company developing RNA-based medicines.* They developed an obesity drug (WVE-007) that showed fat loss comparable to GLP-1s like Ozempic but with *once or twice a year dosing* ***without any muscle loss.*** **Why did $WVE crash?** *Stock dropped* ***50%*** *in a single session* on March 26. They just had a **"miss"** WVE-007 at a ***higher dosage*** showed just **0.9%** weight loss over placebo. FDA wants to see **5%** at least. ***RA …
— ORIGINAL POST ·
My Thesis On $WVE. RA Capital bought $54M after a 50% crash in this Ozempic Competitor.
· r/stocks
· Apr 3, 2026